|
Post-Market Clinical Follow-up of Intra-Articular Hyaluronic Acid in Hip Osteoarthritis
RECRUITINGSponsored by Meiji Pharma Spain S.A.
Actively Recruiting
SponsorMeiji Pharma Spain S.A.
Started2026-01-29
Est. completion2027-04
Eligibility
Age40 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07883395
Summary
The study population consists of approximately 40 adult outpatients aged 40 years or older with symptomatic hip osteoarthritis of at least 1 year of clinical evolution, treated with intra-articular hyaluronic acid in routine clinical practice within the Traumatology and Rehabilitation departments of participating hospitals in Spain.
Eligibility
Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria: * Age: \>40 years at the time of study inclusion * Preserved gait capability, with or without assistive devices * Symptomatic hip arthropathy with a disease evolution of at least 1 year. * Radiographic Kellgren-Lawrence grade II-III documented within the 12 months prior to study entry * Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score \>15 * Patient currently receiving intra-articular hyaluronic acid treatment within 3 months prior to study inclusion Exclusion Criteria: * Refusal to provide written informed consent * Females who are pregnant, breastfeeding, or not using effective contraception * Body Mass Index (BMI) ≥ 30 kg/m² * Presence of other chronic or autoimmune diseases that could interfere with clinical evaluation * History of hypersensitivity or allergy to hyaluronic acid or its derivatives * Prior administration of intra-articular platelet-rich plasma (PRP) or intra-articular corticosteroids within 3 months, or intra-articular hyaluronic acid within 6 months prior to study entry
Conditions2
ArthritisHip OA
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorMeiji Pharma Spain S.A.
Started2026-01-29
Est. completion2027-04
Eligibility
Age40 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07883395